Proteomics Industry Overview:

Proteomics refers to the study of protein structure and physiological function. It includes understanding the modifications and alterations that generally take place in existing proteins when they are subjected to varying conditions. It also studies and analyses which proteins are expressed and their structures in both active and inactive states to further understand their roles and how they interact with other proteins. This is done by the widespread integration of numerous advanced technologies with proteomics for quantifying and identifying proteins and diagnostic markers. Apart from this, it also deals with the evaluation of the rate of protein production as well as the interaction patterns of proteins. As a result, it finds extensive applications in drug discovery and the development of personalized medicines.

The recent report by IMARC Group, titled “Proteomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast  2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the proteomics market size. The report also includes competitor and regional analysis, and contemporary advancements in the market.   The global proteomics market size reached US$ 30.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 77.0 Billion by 2028, exhibiting a growth rate (CAGR) of 17.8% during 2023-2028.

Request for a free sample copy of this report: https://www.imarcgroup.com/proteomics-market/requestsample

Global Proteomics Market Trends:

The global market is majorly driven by the increasing demand for personalized medicines. Along with this, continual developments in drug discovery and biotechnology is providing an impetus to market growth. The deployment of proteomic systems assists in simplifying the process of drug discovery and forms an essential part of the chemical synthesis and biological testing of numerous drugs. The market is further driven by the technological advancements and extensive research and development (R&D) activities conducted by the players. This has led to the development of a quantitative and qualitative analysis of proteins that consequently assists in the identification of cancer therapies and treatments, thereby acting as a major growth-induing factor. Some of the other factors contributing to the market growth include continual developments in the existing healthcare infrastructure and numerous favorable government policies that promote research and drug discovery activities across the globe.

Global Proteomics Market 2023-2028 Analysis and Segmentation:

Competitive Landscape with Key Players:

The report has also analysed the competitive landscape of the market with some of the key players being:

Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Market Segmentation:

Analysis Type:

• Structural Proteomics
• Functional Proteomics
• Protein Expression Proteomics

Component Type:

• Core Proteomics Services
• Bioinformatics Software and Related Services

Technology:

• Spectroscopy
• Chromatography
• Electrophoresis
• Protein Microarrays
• X-Ray Crystallography
• Surface Plasmon Resonance
• Others

Application:

• Protein Expression Profiling
• Proteome Mining
• Post-translational Modifications

End-User:

• Clinical Diagnostic Laboratories
• Research Organizations (Drug Discovery)
• Others

Key highlights of the report:

• Market Performance 
• Market Outlook 
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Competitive Structure
• Profiles of Key Players

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Report Coverage:

Report Features	Details
Base Year of the Analysis	2022
Historical Period	2017-2022
Forecast Period	2023-2028
Units	US$ Billion
Segment Coverage	Analysis Type, Component Type, Technology, Application, End-User, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc. and Waters Corporation
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Read More: https://thecrazypanda.com/